Benzinga's Top #PreMarket Gainers
ArQule (NASDAQ: ARQL) surged 29.24% to $3.05 in the pre-market session after the company reported that the Data Monitoring Committee okayed the continuation of Phase 3 METIV-HCC study.
Skyworks Solutions (NASDAQ: SWKS) shares gained 10.24% to $31.55 in the pre-market after the company reported upbeat Q1 earnings and issued strong Q2 forecast.
Ariad Pharmaceuticals (NASDAQ: ARIA) soared 7.12% to $7.22 in the pre-market trading after the company announced the commercial availability of Iclusig for patients with refractory Philadelphia-positive leukemias in the US.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.